Product Information
METHIMAZOLE 5 MG TABLET is a generic product labeled by American Health Packaging, priced at $0.0707 per EA under NDC 60687066901. Its NADAC has been published 180 times since Dec 14, 2022.
FDA first approved this application on Mar 29, 2000. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
5 mg/1
Manufacturer
American Health PackagingNDC
60687066901
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
METHIMAZOLEApproval Type
Generic (ANDA)
FDA Application
ANDA040350FDA Approved
3/29/2000
TE Code
AB
On Market Since
4/5/2023
Pharmacological Classes
Price Statistics
The NADAC for METHIMAZOLE 5 MG TABLET has been published 180 times since Dec 14, 2022, and over the history we have for it it has risen 5.9%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0707 per EA |
|---|---|
| All-time high | $0.1140 (Sep 13, 2023) |
| All-time low | $0.0640 (Dec 21, 2022) |
| 52-week high | $0.0864 |
| 52-week low | $0.0707 |
| Median price | $0.0770 |
| Average price | $0.0792 |
| Largest weekly change | +32.3% (Aug 30, 2023) |
| Weeks tracked | 180 |
| Tracking since | Dec 14, 2022 |
Generic Alternatives
The matcher finds 4 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of METHIMAZOLE 5 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for METHIMAZOLE 5 MG TABLET, manufactured by American Health Packaging, is $0.0707 per EA (NDC 60687066901), effective Aug 19, 2026.
How has the price of METHIMAZOLE 5 MG TABLET changed over time?
Over the history we have for it, the NADAC for METHIMAZOLE 5 MG TABLET has risen 5.9%. It has been tracked across 180 weekly CMS publications since Dec 14, 2022.
What are the highest and lowest recorded NADAC prices for METHIMAZOLE 5 MG TABLET?
Since Dec 14, 2022, the NADAC for METHIMAZOLE 5 MG TABLET has ranged from a low of $0.0640 (Dec 21, 2022) to a high of $0.1140 (Sep 13, 2023), with a median of $0.0770 per EA.
Are there cheaper alternatives to METHIMAZOLE 5 MG TABLET?
4 manufacturers publish a NADAC-priced product with the same active ingredient and strength as METHIMAZOLE 5 MG TABLET in a comparable dosage form, but none are currently priced below it.
Who manufactures METHIMAZOLE 5 MG TABLET?
METHIMAZOLE 5 MG TABLET (NDC 60687066901) is labeled by American Health Packaging, and CMS classifies it as a generic product.